Diane V. Havlir

48.0k total citations · 9 hit papers
390 papers, 22.3k citations indexed

About

Diane V. Havlir is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Diane V. Havlir has authored 390 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 306 papers in Infectious Diseases, 148 papers in Virology and 145 papers in Epidemiology. Recurrent topics in Diane V. Havlir's work include HIV/AIDS Research and Interventions (201 papers), HIV Research and Treatment (148 papers) and HIV/AIDS drug development and treatment (120 papers). Diane V. Havlir is often cited by papers focused on HIV/AIDS Research and Interventions (201 papers), HIV Research and Treatment (148 papers) and HIV/AIDS drug development and treatment (120 papers). Diane V. Havlir collaborates with scholars based in United States, Uganda and Kenya. Diane V. Havlir's co-authors include Douglas D. Richman, Joseph K. Wong, Steven G. Deeks, Sharon R. Lewin, Huldrych F. Günthard, Celsa A. Spina, Caroline Ignacio, Peter F. Barnes, Moses R. Kamya and Edwin D. Charlebois and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Diane V. Havlir

378 papers receiving 21.8k citations

Hit Papers

Recovery of Replication-Competent HIV Despite Prolonged S... 1994 2026 2004 2015 1997 1997 2013 2000 1999 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
    1997 1.7k citations Diane V. Havlir, Douglas D. Richman et al. profile →
  2. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
    1997 1.5k citations Diane V. Havlir, Douglas D. Richman et al. profile →
  3. The end of AIDS: HIV infection as a chronic disease
    2013 1.4k citations Steven G. Deeks, Diane V. Havlir et al. profile →
  4. HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
    2000 742 citations Diane V. Havlir, Douglas D. Richman et al. profile →
  5. Tuberculosis in Patients with Human Immunodeficiency Virus Infection
    1999 717 citations Diane V. Havlir et al. profile →
  6. Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
    2008 500 citations Diane V. Havlir et al. profile →
  7. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
    1994 487 citations Douglas D. Richman, Diane V. Havlir et al. profile →
  8. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
    2023 202 citations Anne F. Luetkemeyer, Edwin D. Charlebois et al. profile →
  9. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
    2022 89 citations Matthew D. Hickey, Diane V. Havlir et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane V. Havlir United States 68 15.6k 11.7k 6.8k 3.0k 3.0k 390 22.3k
Michael S. Saag United States 84 19.4k 1.2× 15.5k 1.3× 9.5k 1.4× 3.7k 1.3× 4.7k 1.6× 328 28.8k
Joseph J. Eron United States 83 20.8k 1.3× 17.1k 1.5× 7.0k 1.0× 2.4k 0.8× 3.8k 1.3× 465 27.9k
Margaret A. Fischl United States 62 16.5k 1.1× 12.5k 1.1× 6.8k 1.0× 2.0k 0.7× 3.4k 1.1× 268 23.5k
Jeffrey N. Martin United States 79 11.7k 0.8× 11.6k 1.0× 6.7k 1.0× 5.7k 1.9× 5.3k 1.8× 340 23.5k
Andrew Phillips United Kingdom 81 18.5k 1.2× 12.3k 1.0× 8.2k 1.2× 1.2k 0.4× 8.7k 2.9× 563 27.6k
Robert W. Coombs United States 59 11.8k 0.8× 8.9k 0.8× 5.7k 0.8× 1.6k 0.5× 1.8k 0.6× 235 16.8k
Brian Gazzard United Kingdom 77 12.2k 0.8× 8.9k 0.8× 7.0k 1.0× 2.4k 0.8× 3.3k 1.1× 494 21.8k
Richard E. Chaisson United States 87 21.7k 1.4× 8.2k 0.7× 15.6k 2.3× 2.2k 0.7× 2.2k 0.7× 370 28.4k
John Phair United States 69 11.0k 0.7× 9.5k 0.8× 7.6k 1.1× 4.0k 1.4× 3.0k 1.0× 353 22.0k
Scott D. Holmberg United States 73 14.4k 0.9× 7.3k 0.6× 13.5k 2.0× 1.2k 0.4× 4.7k 1.6× 200 26.9k

Countries citing papers authored by Diane V. Havlir

Since Specialization
Citations

This map shows the geographic impact of Diane V. Havlir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane V. Havlir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane V. Havlir more than expected).

Fields of papers citing papers by Diane V. Havlir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane V. Havlir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane V. Havlir. The network helps show where Diane V. Havlir may publish in the future.

Co-authorship network of co-authors of Diane V. Havlir

This figure shows the co-authorship network connecting the top 25 collaborators of Diane V. Havlir. A scholar is included among the top collaborators of Diane V. Havlir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane V. Havlir. Diane V. Havlir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hickey, Matthew D., James Ayieko, Jane Kabami, et al.. (2025). Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: An individual-based modeling study. PLoS Medicine. 22(1). e1004531–e1004531. 1 indexed citations
3.
Mwangwa, Florence, Gabriel Chamie, Laura B. Balzer, et al.. (2023). Effect of a brief alcohol counselling intervention on HIV viral suppression and alcohol use among persons with HIV and unhealthy alcohol use in Uganda and Kenya: a randomized controlled trial. Journal of the International AIDS Society. 26(12). e26187–e26187. 4 indexed citations
4.
Acharya, Charlotte B., Anthea Mitchell, David A. Coil, et al.. (2022). Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infectious Diseases. 9(5). ofac135–ofac135. 39 indexed citations
5.
Laurie, Matthew T., Jamin Liu, Sara Sunshine, et al.. (2022). SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. The Journal of Infectious Diseases. 225(11). 1909–1914. 29 indexed citations
6.
Hickey, Matthew D., Asiphas Owaraganise, Norton Sang, et al.. (2022). Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial. PLoS ONE. 17(11). e0277312–e0277312. 8 indexed citations
7.
Jewell, Britta L., Laura B. Balzer, Tamara D. Clark, et al.. (2021). Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(4). 1024–1031. 5 indexed citations
8.
Kerkhoff, Andrew D., Darpun Sachdev, Susy Rojas, et al.. (2020). Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations. PLoS ONE. 15(10). e0239400–e0239400. 39 indexed citations
9.
Balzer, Laura B., James Ayieko, Dalsone Kwarisiima, et al.. (2020). Far from MCAR. Epidemiology. 31(5). 620–627. 7 indexed citations
10.
Appa, Ayesha, Saki Takahashi, Isabel Rodríguez-Barraquer, et al.. (2020). Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infectious Diseases. 8(1). ofaa531–ofaa531. 6 indexed citations
11.
Marquez, Carina, Gabriel Chamie, Jane Achan, et al.. (2016). Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. The Pediatric Infectious Disease Journal. 35(5). 524–529. 25 indexed citations
12.
Koss, Catherine A., Paul Natureeba, Julia Mwesigwa, et al.. (2015). Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 29(7). 825–830. 49 indexed citations
13.
Natureeba, Paul, Veronica Ades, Julia Mwesigwa, et al.. (2014). Lopinavir/Ritonavir-Based Antiretroviral Treatment (ART) Versus Efavirenz-Based ART for the Prevention of Malaria Among HIV-Infected Pregnant Women. The Journal of Infectious Diseases. 210(12). 1938–1945. 40 indexed citations
14.
Luetkemeyer, Anne F., Haileyesus Getahun, Gabriel Chamie, Christian Lienhardt, & Diane V. Havlir. (2011). Tuberculosis Drug Development: Ensuring People Living with HIV Are Not Left Behind. American Journal of Respiratory and Critical Care Medicine. 184(10). 1107–1113. 16 indexed citations
15.
Robertson, K. R., Zhaohui Su, David M. Margolis, et al.. (2010). Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 74(16). 1260–1266. 167 indexed citations
16.
Ssewanyana, Isaac, Chris A. R. Baker, Theodore Ruel, et al.. (2009). The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. AIDS Research and Human Retroviruses. 25(1). 65–71. 17 indexed citations
17.
Luetkemeyer, Annie, Edwin D. Charlebois, Laura Flores, et al.. (2007). Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals. American Journal of Respiratory and Critical Care Medicine. 175(7). 737–742. 168 indexed citations
18.
Parikh, Sunil, Jiří Gut, Eva S. Istvan, et al.. (2005). Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 49(7). 2983–2985. 110 indexed citations
19.
Pollard, Richard B., Camlin Tierney, Diane V. Havlir, et al.. (2002). A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298). AIDS Research and Human Retroviruses. 18(10). 699–704. 7 indexed citations
20.
Havlir, Diane V., Michael P. Dubé, J. Allen McCutchan, et al.. (1998). Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS. Clinical Infectious Diseases. 27(6). 1369–1375. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael S. Saag Breakdown of academic impact, for papers by Joseph J. Eron Breakdown of academic impact, for papers by Margaret A. Fischl Breakdown of academic impact, for papers by Jeffrey N. Martin Breakdown of academic impact, for papers by Andrew Phillips Breakdown of academic impact, for papers by Robert W. Coombs Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by Richard E. Chaisson Breakdown of academic impact, for papers by John Phair Breakdown of academic impact, for papers by Scott D. Holmberg
Rankless by CCL
2026